Xu et al. reported that PARPBP expression was enhanced in lung adenocarcinoma tissues and correlated with poor prognosis in lung adenocarcinoma patients (59) and also that its high expression was closely correlated with pathologic stages, suggesting its utility as an independent predictor in lung adenocarcinoma patients. Here, PARPBP is linked to lung adenocarcinoma.